CANVAC DHPL

lyophilizate and solvent for suspension for injection for dogs

Composition:

Each one dose (1 ml) contains:
Attenuated canine distemper virus (CDV) 102.7 – 104.5 EID50, Attenuated canine adenovirus type 2 (CAV-2) 103.5 -107.5 CCID50, Attenuated canine parvovirus type 2 (CPV-2) 102.1 – 103.6 HAU, inactivated Leptospira icterohaemorrhagiae q. s. at an amount, which induces a serological response in experimental animals at a titer of NLT 1:32 of specific antibodies, inactivated Leptospira grippotyphosa q. s. at an amount, that induces a serological response in experimental animals at titer of NLT 1:32 of specific antibodies, inactivated Leptospira inactivata q. s. at an amount, which induces a serological response in experimental animals at titer of NLT 1:32 of specific antibodies.

Indication:

For an active prophylactic immunization of dogs from 6 weeks of age against distemper, infectious hepatitis, parvovirosis of dogs and leptospirosis caused by serovars L. icterohaemorrhagiae, L. grippotyphosa and L. sejroe. Sufficient immunity develops over 2 to 3 weeks after the primary vaccination and persists for at least 1 year.

Dosage:

Per animal dose is 1 ml irrespective of species, age, weight and sex of the vaccinated.

Pack sizes:

6 x 1 dose